List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 145 studies with search of: "Levodopa"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Not yet recruiting Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects
Condition: Advanced Parkinson's Disease
Interventions: Drug: levodopa-carbidopa intestinal gel with placebo capsules;   Drug: levodopa-carbidopa intestinal placebo gel with active oral medication (capsules containing levodopa-carbidopa tablets);   Device: CADD-Legacy® 1400 ambulatory infusion pump
2 Recruiting Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects
Condition: Advanced Parkinson's Disease
Interventions: Drug: levodopa-carbidopa intestinal gel with placebo capsules;   Drug: levodopa-carbidopa intestinal placebo gel with active oral medication (capsules containing levodopa-carbidopa tablets);   Device: CADD-Legacy® 1400 ambulatory infusion pump
3 Recruiting Pilot Study to Evaluate Levodopa as Treatment for Residual Amblyopia
Condition: Amblyopia
Interventions: Drug: levodopa/carbidopa;   Device: patching;   Drug: levodopa/carbidopa
4 Terminated Carbidopa/Levodopa/Entacapone Versus Immediate Release (IR) Carbidopa/Levodopa on Non-Motor Symptoms in Patients With Idiopathic Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: Carbidopa/levodopa/entacapone, IR carbidopa/levodopa;   Drug: Carbidopa/levodopa/entacapone, IR carbidopa/levodopa
5 Terminated Carbidopa/Levodopa Versus Carbidopa/Levodopa/Entacapone on Markers of Event Related Potentials (ERPs) in Patients With Idiopathic Parkinson's Disease (PD) and End-of-Dose Wearing Off
Condition: Parkinson's Disease
Interventions: Drug: carbidopa/levodopa;   Drug: Carbidopa/Levodopa/Entacapone
6 Recruiting Study on Tolerability of Levodopa/Carbidopa in Children With Angelman Syndrome
Condition: Angelman Syndrome
Intervention: Drug: Levodopa/Carbidopa (4:1)
7 Not yet recruiting Acute Effects of SCH 420814 on Dyskinesia and Parkinsonism in Levodopa Treated Patients (Study P05550AM1)
Conditions: Movement Disorders;   Dyskinesias;   Neurodegenerative Diseases;   Central Nervous System Diseases;   Brain Diseases
Interventions: Drug: Preladenant;   Drug: Preladenant;   Drug: Levodopa infusion (IV);   Drug: Carbidopa;   Drug: Placebo matched to preladenant;   Drug: Placebo matched to Levodopa infusion (IV);   Drug: Placebo matched to Carbidopa 25-mg
8 Recruiting Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced PD
Condition: Advanced Parkinson's Disease
Interventions: Drug: Levodopa-Carbidopa intestinal gel;   Device: CADD-Legacy® 1400
9 Not yet recruiting Safety/Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Parkinson's Subjects
Conditions: Parkinson's Disease;   Severe Motor Fluctuations;   Dyskinesia
Interventions: Drug: Levodopa-carbidopa intestinal gel;   Device: CADD-Legacy® 1400
10 Active, not recruiting Developing Objective Measures of Levodopa Induced Dyskinesia: (Study 1)
Conditions: Dyskinesias;   Movement Disorders;   Parkinson Disease
Intervention: Drug: Levodopa (delivered intravenously)
11 Active, not recruiting Efficacy of Levodopa/Carbidopa/Entacapone vs. Levodopa/Carbidopa in Parkinson's Disease Patients With Early Wearing Off
Condition: Parkinson's Disease
Intervention: Drug: Levodopa/carbidopa/entacapona
12 Not yet recruiting Open Label Continuation Treatment Study With Levodopa-Carbidopa Intestinal Gel in Advanced PD
Condition: Advanced Parkinson's Disease
Interventions: Drug: Levodopa-carbidopa intestinal gel;   Device: CADD-Legacy® 1400 ambulatory infusion pump
13 Recruiting Dopaminergic Effects on Cortical Function in Tourette's (Levodopa Protocol)
Condition: Tourette Syndrome
Interventions: Drug: levodopa solution for i.v. administration;   Drug: placebo
14 Completed A Study to Evaluate Fixed Dose Carbidopa/Levodopa/Entacapone Versus Immediate Release Carbidopa/Levodopa
Condition: Parkinson's Disease
Intervention: Drug: capsules containing: carbidopa (25 mg), levodopa (100 mg), entacapone (200 mg)
15 Completed Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone in Healthy Volunteers
Condition: Healthy
Intervention: Drug: ELC200 (carbidopa+levodopa+entacapone)
16 Completed Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone in Healthy Volunteers
Condition: Healthy
Intervention: Drug: ELC200 (carbidopa+levodopa+entacapone)
17 Completed Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone in Healthy Volunteers
Condition: Healthy
Intervention: Drug: ELC200 (carbidopa+levodopa+entacapone)
18 Completed Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone Under Fasting Conditions in Healthy Volunteers
Condition: Healthy
Intervention: Drug: ELC200 (carbidopa+levodopa+entacapone)
19 Active, not recruiting Efficacy and Safety of Carbidopa/Levodopa/Entacapone in Patients With Parkinson's Disease Requiring Initiation of Levodopa Therapy
Condition: Parkinson's Disease
Intervention: Drug: carbidopa, levodopa, entacapone
20 Completed Effect of Levodopa on Human Multifocal Electroretinogram
Condition: Retinal Diseases
Intervention: Drug: levodopa

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services